ARTICLE | Distillery Therapeutics
Therapeutics: Insulin-like growth factor-1 (IGF-1) receptor (IGF1R; CD221)
January 8, 2015 8:00 AM UTC
Mouse studies suggest a hydroximic acid derivative called BGP-15 could help treat heart failure and atrial fibrillation. In a transgenic mouse model of heart failure with atrial fibrillation, orally d...